Lipoprotein abnormalities in hemodialysis and continuous ambulatory peritoneal dialysis patients.
about
Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study.Therapeutic potential of low-density lipoprotein apheresis in the management of peripheral artery disease in patients with chronic kidney disease.Effects of Ginger on Serum Lipids and Lipoproteins in Peritoneal Dialysis Patients: A Randomized Controlled Trial.
P2860
Lipoprotein abnormalities in hemodialysis and continuous ambulatory peritoneal dialysis patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Lipoprotein abnormalities in h ...... peritoneal dialysis patients.
@en
Lipoprotein abnormalities in h ...... peritoneal dialysis patients.
@nl
type
label
Lipoprotein abnormalities in h ...... peritoneal dialysis patients.
@en
Lipoprotein abnormalities in h ...... peritoneal dialysis patients.
@nl
prefLabel
Lipoprotein abnormalities in h ...... peritoneal dialysis patients.
@en
Lipoprotein abnormalities in h ...... peritoneal dialysis patients.
@nl
P2093
P356
P1433
P1476
Lipoprotein abnormalities in h ...... peritoneal dialysis patients.
@en
P2093
Christina I Fytili
Elias D Thodis
Euaggelia G Progia
Kostas I Sombolos
Ploumis S Passadakis
Stelios A Panagoutsos
Vassilis A Vargemezis
P2860
P304
P356
10.1081/JDI-120013966
P577
2002-09-01T00:00:00Z